jcp conference-coverage

Conference Coverage

2019 Oncology Clinical Pathways Congress

10/18/2019

JCP Editors

Now in its fourth year, the Oncology Clinical Pathways Congress (OCPC) serves as a forum for oncology care professionals interested in utilizing clinical pathways as a tool to facilitate more value-based care...

Now...

10/18/2019

Journal of Clinical Pathways

Conference Coverage

European Society of Medical Oncology Annual Congress 2019

10/18/2019

JCP Editors

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 27.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 10.0px Helvetica} p.p3...

p.p1...

10/18/2019

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology 2019 Annual Meeting

06/18/2019

JCP Editors

The American Society of Clinical Oncology (ASCO) is the leading professional organization for physicians and oncology professionals caring for people with cancer. Through its multidisciplinary network of almost...

The...

06/18/2019

Journal of Clinical Pathways

Conference Coverage

2018 American Society of Hematology Annual Meeting & Exposition

02/19/2019

JCP Editors

The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100 countries. The...

The...

02/19/2019

Journal of Clinical Pathways

Conference Coverage

2018 San Antonio Breast Cancer Symposium

12/13/2018

JCP Editors

The 2018 San Antonio Breast Cancer Symposium (SABCS) brought together more than 7000 physicians and researchers from around the globe from December 4 through 8 in San Antonio, Texas.  SABCS began in 1977 as a...

The...

12/13/2018

Journal of Clinical Pathways

Conference Coverage

American Society of Hematology 2018 Annual Meeting & Exposition

12/13/2018

JCP Editors

The...

12/13/2018

Journal of Clinical Pathways

Conference Coverage

European Society for Medical Oncology 2018 Congress

11/19/2018

JCP Editors

The European Society for Medical Oncology (ESMO) is Europe’s leading professional organization for medical oncology education and information. With over 13,000 members representing oncology professionals from more...

The...

11/19/2018

Journal of Clinical Pathways

Conference Coverage

Academy of Managed Care Pharmacy Nexus 2018

11/18/2018

JCP Editors

The Academy of Managed Care Pharmacy (AMCP) is the leading professional organization for practitioners invested in the development and implementation of value-based care pathways within the managed care setting....

The...

11/18/2018

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology Quality Care Symposium

10/15/2018

JCP Editors

First launched in 2012, the American Society of Clinical Oncology (ASCO) Quality Care Symposium brings together a multidisciplinary faculty to educate attendees on the latest innovations and collaborations in quality...

First...

10/15/2018

Journal of Clinical Pathways

Conference Coverage

ESMO World Congress on Gastrointestinal Cancer 2018

08/22/2018

JCP Editors

With over 18,000 members representing oncology professionals from over 150 countries, the European Society for Medical Oncology (ESMO) is the leading professional organization for medical oncology. ESMO’s educational...

With...

08/22/2018

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products